BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15548369)

  • 1. Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing.
    Kurtz A; Aigner A; Cabal-Manzano RH; Butler RE; Hood DR; Sessions RB; Czubayko F; Wellstein A
    Neoplasia; 2004; 6(5):595-602. PubMed ID: 15548369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation.
    Schmidt MO; Garman KA; Lee YG; Zuo C; Beck PJ; Tan M; Aguilar-Pimentel JA; Ollert M; Schmidt-Weber C; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; ; Tassi E; Riegel AT; Wellstein A
    J Invest Dermatol; 2018 Jan; 138(1):179-188. PubMed ID: 28864076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
    Elson DA; Ryan HE; Snow JW; Johnson R; Arbeit JM
    Cancer Res; 2000 Nov; 60(21):6189-95. PubMed ID: 11085544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenesis in human skin grafted to SCID mice.
    Soballe PW; Montone KT; Satyamoorthy K; Nesbit M; Herlyn M
    Cancer Res; 1996 Feb; 56(4):757-64. PubMed ID: 8631010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation.
    Rossiter H; Barresi C; Pammer J; Rendl M; Haigh J; Wagner EF; Tschachler E
    Cancer Res; 2004 May; 64(10):3508-16. PubMed ID: 15150105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
    Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
    Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
    Arbeit JM; Olson DC; Hanahan D
    Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of fibroblast growth factor (FGF) 9 expression and FGF-WNT/β-catenin signaling in laser-induced wound healing.
    Zheng Z; Kang HY; Lee S; Kang SW; Goo B; Cho SB
    Wound Repair Regen; 2014; 22(5):660-5. PubMed ID: 25041895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis.
    Antsiferova M; Martin C; Huber M; Feyerabend TB; Förster A; Hartmann K; Rodewald HR; Hohl D; Werner S
    J Immunol; 2013 Dec; 191(12):6147-55. PubMed ID: 24227781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
    Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
    Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.